Original research
par
Gottlieb, Daniel J. et al
Date de publication
2022
Géographie
USA
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
Our objective was to compare mortality rates for buprenorphine and methadone treatments among a large sample of US patients with OUD.
Constatations/points à retenir
We found significantly lower all-cause mortality and suicide mortality rates for buprenorphine compared with methadone. Our results support the less restrictive prescribing practices for buprenorphine as OAT in the US.
La conception ou méthodologie de recherche
US Department of Veterans Affairs data from 2010 through 2019.
Mots clés
Mortality
Substitution/OAT
Outcomes
